erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
RSL3 - Stanford University
Ferroptosis as the new approach to cancer therapy. (PubMed, Cancer Treat Res Commun) - Apr 6, 2025 - "For instance, in a study involving breast cancer models, the use of ferroptosis inducers such as erastin and RSL3 led to a marked decrease in tumor volume and weight. This review aims to explore the potential of ferroptosis as a novel therapeutic strategy in cancer treatment." 
Journal • Review • Breast Cancer • Oncology • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/40187205
 
Adebola Busola Ojo; Emmanuel Henry Ezenabor; Oluwafemi Adeleke Ojo; Pearl Ifunanya Nwafor-Ezeh; Susan Grant; Tobiloba Christiana Maduakolam-Aniobi; Tolulope Isaiah Akinborode
 
Apr 6, 2025
 
Prev Next